168 related articles for article (PubMed ID: 33187976)
1. High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning.
McDonnell M; Harris RJ; Borca F; Mills T; Downey L; Dharmasiri S; Patel M; Zare B; Stammers M; Smith TR; Felwick R; Cummings JRF; Phan HTT; Gwiggner M
BMJ Open Gastroenterol; 2020 Nov; 7(1):. PubMed ID: 33187976
[TBL] [Abstract][Full Text] [Related]
2. Predicting Hospitalization and Outpatient Corticosteroid Use in Inflammatory Bowel Disease Patients Using Machine Learning.
Waljee AK; Lipson R; Wiitala WL; Zhang Y; Liu B; Zhu J; Wallace B; Govani SM; Stidham RW; Hayward R; Higgins PDR
Inflamm Bowel Dis; 2017 Dec; 24(1):45-53. PubMed ID: 29272474
[TBL] [Abstract][Full Text] [Related]
3. Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia.
Rhou YJJ; Hor A; Wang M; Wu YF; Jose S; Chipps DR; Cheung NW
Diabetes Res Clin Pract; 2022 Dec; 194():110151. PubMed ID: 36375566
[TBL] [Abstract][Full Text] [Related]
4. Disease Characteristics and Severity in Patients With Inflammatory Bowel Disease With Coexistent Diabetes Mellitus.
Din H; Anderson AJ; Ramos Rivers C; Proksell S; Koutroumpakis F; Salim T; Babichenko D; Tang G; Koutroubakis IE; Schwartz M; Johnston E; Barrie A; Harrison J; Hashash J; Dunn MA; Hartman DJ; Binion DG
Inflamm Bowel Dis; 2020 Aug; 26(9):1436-1442. PubMed ID: 31944255
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for the development of glucocorticoid-induced diabetes mellitus.
Katsuyama T; Sada KE; Namba S; Watanabe H; Katsuyama E; Yamanari T; Wada J; Makino H
Diabetes Res Clin Pract; 2015 May; 108(2):273-9. PubMed ID: 25765669
[TBL] [Abstract][Full Text] [Related]
6. IL-6 may modulate the skeletal response to glucocorticoids during exacerbations of inflammatory bowel disease.
Kriel M; Sayers A; Fraser WD; Williams AM; Koch A; Zacharowski K; Probert CS; Tobias JH
Calcif Tissue Int; 2010 May; 86(5):375-81. PubMed ID: 20229252
[TBL] [Abstract][Full Text] [Related]
7. Effect of hyperglycaemia on inflammatory and stress responses and clinical outcome of pneumonia in non-critical-care inpatients: results from an observational cohort study.
Schuetz P; Friedli N; Grolimund E; Kutz A; Haubitz S; Christ-Crain M; Thomann R; Zimmerli W; Hoess C; Henzen C; Mueller B;
Diabetologia; 2014 Feb; 57(2):275-84. PubMed ID: 24270903
[TBL] [Abstract][Full Text] [Related]
8. Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil.
Schmidt MI; Bracco PA; Yudkin JS; Bensenor IM; Griep RH; Barreto SM; Castilhos CD; Duncan BB
Lancet Diabetes Endocrinol; 2019 Apr; 7(4):267-277. PubMed ID: 30803929
[TBL] [Abstract][Full Text] [Related]
9. Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia.
Cheng YC; Guerra Y; Morkos M; Tahsin B; Onyenwenyi C; Fogg L; Fogelfeld L
PLoS One; 2021; 16(9):e0256682. PubMed ID: 34529703
[TBL] [Abstract][Full Text] [Related]
10. Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease.
Gan RW; Sun D; Tatro AR; Cohen-Mekelburg S; Wiitala WL; Zhu J; Waljee AK
PLoS One; 2021; 16(9):e0257520. PubMed ID: 34543353
[TBL] [Abstract][Full Text] [Related]
11. Comorbid Diabetes in Inflammatory Bowel Disease Predicts Adverse Disease-Related Outcomes and Infectious Complications.
Kumar A; Teslova T; Taub E; Miller JD; Lukin DJ
Dig Dis Sci; 2021 Jun; 66(6):2005-2013. PubMed ID: 32617771
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a basal bolus insulin protocol to treat prednisolone-induced hyperglycaemia in hospitalised patients.
Burt MG; Drake SM; Aguilar-Loza NR; Esterman A; Stranks SN; Roberts GW
Intern Med J; 2015 Mar; 45(3):261-6. PubMed ID: 25565560
[TBL] [Abstract][Full Text] [Related]
13. HbA₁c versus oral glucose tolerance test as a method to diagnose diabetes mellitus in vascular surgery patients.
Hjellestad ID; Astor MC; Nilsen RM; Søfteland E; Jonung T
Cardiovasc Diabetol; 2013 May; 12():79. PubMed ID: 23705980
[TBL] [Abstract][Full Text] [Related]
14. The high incidence of steroid-induced hyperglycaemia in hospital.
Fong AC; Cheung NW
Diabetes Res Clin Pract; 2013 Mar; 99(3):277-80. PubMed ID: 23298665
[TBL] [Abstract][Full Text] [Related]
15. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
16. Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease.
Koskela HO; Salonen PH; Niskanen L
Clin Respir J; 2013 Oct; 7(4):382-9. PubMed ID: 23902130
[TBL] [Abstract][Full Text] [Related]
17. Unmet Needs of Glycaemic Control and Risk Factors of Residual Hyperglycaemia in a Chinese Population with Type 2 Diabetes Initiating Basal Insulin: A Post Hoc Analysis of the FPG GOAL Study.
Wang X; Wu G; Shen D; Zhang X; Yang W
Adv Ther; 2022 Jun; 39(6):2820-2830. PubMed ID: 35430674
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein in paediatric inflammatory bowel disease.
Sidoroff M; Karikoski R; Raivio T; Savilahti E; Kolho KL
World J Gastroenterol; 2010 Jun; 16(23):2901-6. PubMed ID: 20556836
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke.
Gray CS; Scott JF; French JM; Alberti KG; O'Connell JE
Age Ageing; 2004 Jan; 33(1):71-7. PubMed ID: 14695867
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
